MJardin Group Announces Participation at Upcoming Investor Conferences
DENVER--(BUSINESS WIRE)--Jan 9, 2019--MJardin Group, Inc. (“ MJardin ” or the “ Company ”) (CSE:MJAR), a leader in cannabis management, today announced the Company’s participation at upcoming investor conferences.
Rishi Gautam, the Company’s Chairman and Chief Executive Officer, will present and meet with investors at the 21st Annual ICR Conference in Orlando, Florida at 1:00 p.m. EST on Tuesday, January 15, 2019. The presentation will be webcast live and available on the Company’s website at https://www.mjardin.com/ in the Investors - Events and Presentations section or directly at http://wsw.com/webcast/icr5/mjar/.
Mr. Gautam will also participate in a cannabis panel at the ICR Conference titled “Cannabis Investing: Capitalizing on a New Global Asset Class,” hosted by Vivien Azer, Managing Director and Senior Research Analyst specializing in the beverage, tobacco, and cannabis sectors at Cowen and Company.
Art Brown, the Company’s Chief Accounting Officer, will participate in a panel titled “Expanding Your Business: Organizational & Tax Structuring to Support Growth,” at the CohnReznick Cannabis Conference in Los Angeles, California on Thursday, January 10, 2019.
Frank Knuettel II will present and meet with investors at the Benzinga Cannabis Capital Conference in Miami, Florida at 11:00 a.m. EST on Wednesday, January 16, 2019.
About MJardin Group
MJardin is a global cannabis management platform with extensive experience in cultivation, processing, distribution and retail. For over 10 years, MJardin has refined cultivation methodologies, developed state of the art facilities and implemented vertical integration for and on behalf of license owners. As a well-capitalized organization, MJardin continues to pursue strategic expansion and M&A opportunities across global legal cannabis markets. MJardin is based in Denver, Colorado, with offices in Toronto, Canada and Barcelona, Spain. For more information, please visit www.mjardin.com.
About The ICR Conference
The ICR Conference is a unique platform where public and private company management teams, institutional investors, sell-side research analysts, investment bankers, private equity professionals and select media connect and network with one another as the year begins. The event is one of the largest investment conferences of the year, featuring presentations by more than 150 public and private companies, with attendance regularly exceeding 2,300. For more information please visit http://www.icrconference.com.
About The CohnReznick Cannabis Conference
In its inaugural year, CohnReznick’s Cannabis conference in Los Angeles will draw investors, operators, growers and manufacturers in the sector to discuss practical solutions on how to expand their cannabis business and invest in the industry. Attendees will include Chief Executive Officers, Chief Financial Officers, Chief Investment Officers and their direct reports from early stage to middle market cannabis companies and investment firms. For more information please visit https://events.attend.com/f/1383785664.
About The Benzinga Cannabis Capital Conference
The 2 nd annual Cannabis Capital Conference, hosted by Benzinga, is a premier gathering of cannabis entrepreneurs and investors in North America. The event attracts over 500 attendees including institutional investors, private investors, and both public and private cannabis companies. For more information please visit http://www.benzingacannabisconference.com.
The CSE has not in any way passed upon the merits of and has neither approved nor disapproved the contents of this news release.
This news release contains forward-looking information based on current expectations. Statements about, among other things, future developments and the business and operations of MJardin, the cannabis sales license discussed in this press release, the growth of or global footprint and our intentions to leverage our scale for continued organic growth and to pursue strategic investments are all forward-looking information. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Such factors include, but are not limited to: our ability to identify and pursue growth, financing and other strategic objectives, and the regulatory and economic environments in the jurisdictions we operate or intend to operate or investment in. Although such statements are based on management’s reasonable assumptions at the date such statements are made, there can be no assurance that the proposed acquisition will occur and that such forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such forward-looking information. Accordingly, readers should not place undue reliance on the forward-looking information. MJardin assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by applicable law.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190109005237/en/
CONTACT: Media Contact:
Capital Markets & Investor Relations
Frank Knuettel II, 720-613-4019
Chief Strategy Officer
KEYWORD: UNITED STATES NORTH AMERICA CANADA CALIFORNIA COLORADO FLORIDA
INDUSTRY KEYWORD: HEALTH ALTERNATIVE MEDICINE NATURAL RESOURCES AGRICULTURE RETAIL SPECIALTY
SOURCE: MJardin Group, Inc.
Copyright Business Wire 2019.
PUB: 01/09/2019 08:00 AM/DISC: 01/09/2019 08:00 AM